Reply to E. K. Bartlett et al and A. H. R. Varey et al-Reference-Cited by-同舟云学术

Reply to E. K. Bartlett et al and A. H. R. Varey et al

Published:2020-11 Issue:4 Volume: Page:992-994
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Bellomo Domenico¹,Bridges Alina G.¹,Hieken Tina J.¹,Meves Alexander¹

Affiliation:

1. Domenico Bellomo, PhD, SkylineDx, Rotterdam, The Netherlands; Alina G. Bridges, DO, Department of Laboratory Medicine and Pathology, and Department of Dermatology, Mayo Clinic, Rochester, MN; Tina J. Hieken, MD, Department of Surgery, Mayo Clinic, Rochester, MN; and Alexander Meves, MD, Department of Dermatology, Mayo Clinic, Rochester, MN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.20.00289

Reference10 articles.

1. Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma

2. Validation of a clinicopathological and gene expression profile (CP-GEP) model for sentinel lymph node metastasis in primary cutaneous melanoma

3. A protocol for building and evaluating predictors of disease state based on microarray data

4. Internal validation of predictive models

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CP-GEP (Merlin) gene expression profiling: can my melanoma patient forgo sentinel lymph node biopsy?;Italian Journal of Dermatology and Venereology;2023-08

2. Breslow thickness 2.0: Why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies;Modern Pathology;2022-11

3. Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study;International Journal of Dermatology;2022-01-31

4. The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model;European Journal of Cancer;2021-11